Freedom of Information requests to the Medicines & Healthcare products Regulatory Agency, May 2021
1 Further authorisation of Innova LFTs I note that MHRA’s ‘authorisation of special use of DHSC COVID-19 Self-Test Kit’ dated 22 December 2020 states that “If this authorisation ends on 22/06/2021, and there continues to be a need for a…
Letter to Infected Blood Inquiry, 27 May 2021
To the Secretary, Infected Blood Inquiry Thank you for your letter of 26 May 2021. I am disappointed by your position to deny access to the public hearings, and by your reasoning. As you correctly state, the MHRA authorises (Innova)…
Misuse of lateral flow tests
An email sent to Dr June Raine, chief executive of the Medicines & Healthcare products Regulatory Agency23 May 2021 Dear Dr June Raine, I am writing to draw your attention to the ways in which the government is expanding the…
Covid-19: local implementation of tracing and testing programmes could enable some schools to reopen
Originally published as a letter in the BMJ, 24 March 2020: BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m1187 As a public health physician, I am increasingly concerned about the apparent failure to implement fundamental public health measures to tackle the covid-19 outbreak—specifically, community contact tracing, clinical…
We need hands-on public health expertise to tackle COVID-19
The government has released its scientific evidence, which sheds light on the fiasco and the catastrophe that is unfolding economically, socially, and health wise. It also highlights the lack of public health input and the decimation of the speciality and…